Autoimmune Hepatitis

Recurrent hepatitis can remain undetected after liver transplantation

Published in Hepatitis Weekly, June 2nd, 2003

by Sonia Nichols, senior medical writer - A recent study has shown that patients who undergo liver transplantation for autoimmune hepatitis may have recurrent liver disease that isn't detected in standard liver function testing schemes.

Patient follow-up is essential for determining whether or not autoimmune hepatitis (AIH) reappears after orthotopic liver transplantation. Follow-up regimens can include liver function tests and liver biopsies. Researchers in France now report that tests for biochemical recurrence may not depict an accurate picture of liver health in transplanted AIH patients. They have advised that long-term follow-up should include regular liver...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Hepatitis Weekly

Source: Hepatitis Weekly (2003-06-02)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry